Skip to main content

Market Overview

Why Sorrento Therapeutics Is Trading Higher Today

Why Sorrento Therapeutics Is Trading Higher Today

Sorrento Therapeutics  (NASDAQ: SRNE) shares are trading higher after the company reported positive preliminary results for its Phase 1 study of COVI-MSC for the treatment of ICU COVID-19 patients.

Sorrento Therapeutics is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.

Sorrento Therapeutics shares were trading up 48.22% at $15.44. The stock has a 52-week high of $19.39 and a 52-week low of $1.55.


Related Articles (SRNE)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at